Neoadjuvant Treatment of Nonfunctioning Pancreatic Neuroendocrine Tumors with [177Lu-DOTA0,Tyr3]Octreotate Abstract #665

Introduction: Surgery is the only potential for cure in patients with pancreatic neuroendocrine tumors (pNETs).
Aim(s): To describe the neoadjuvant use of [177Lu-DOTA0,Tyr3]octreotate (177Lu-octreotate) in nonfunctioning pNETs.
Materials and methods: We studied 119 Dutch patients with a nonfunctioning pNET treated with 177Lu-octreotate. Patients were divided into three groups: locally advanced tumor (group 1); ≤3 liver metastases (group 2); >3 liver metastases/other distant metastases (group 3). Patients in group 1+2 were considered neoadjuvant treated patients.
Conference: 10th Annual ENETS Conference 2013 (2013)
Category: Surgical treatment
Presenting Author: Esther I Van Vliet

To read results and conclusion, please login ...

Further abstracts you may be interested in

No result